Multiple KRAS mutations detected by cancer related DNA in patients with resected pancreas adenocarcinoma during treatment with TG01/GM-CSF and gemcitabine (CT TG01-01)
Affiliation
Molecular and Clinical Cancer Medicine, University of Liverpool Cancer Research UK Center, Liverpool,Issue Date
2019
Metadata
Show full item recordCitation
Palmer D, Møller AS, Greenhalf B, Ma YT, Valle JW, Gjertsen TJ, et al. Multiple KRAS mutations detected by cancer related DNA in patients with resected pancreas adenocarcinoma during treatment with TG01/GM-CSF and gemcitabine (CT TG01-01). Annals of Oncology. 2019;30:xi7-xi8.Journal
Annals of OncologyDOI
10.1093/annonc/mdz447.022Additional Links
https://dx.doi.org/10.1093/annonc/mdz447.022Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdz447.022